FDA Device Regulation: 510(k), PMA

Loading...
Thumbnail Image
Penn collection
Academic Entrepreneurship for Health & Medical Professionals
Degree type
Discipline
Subject
Entrepreneurial and Small Business Operations
Funder
Grant number
Copyright date
Distributor
Related resources
Author
Van Batavia, Jason
Goldenberg, Seth
Contributor
Abstract

For latest version: please go to https://academicentrepreneurship.pubpub.org/pub/gxp74m44/release/4 In the U.S., medical devices are classified into one of three groups based on potential risk to patients and this plays an important role in determining the appropriate FDA regulatory pathway. The three most common regulatory pathways through which the FDA clears or approves devices are: 1) exemption status, 2) 510(k), and 3) premarket approval (PMA). Early understanding of likely pathways is essential for planning device design and research strategy. All devices with more than a low or non-significant risk potential must be granted clearance, approval, or an Investigational Device Exemption (IDE) from the FDA prior to use in human subjects. Pre-submission, or Q-sub meetings, allow innovators and device companies to meet with the FDA for free and obtain feedback on the potential pathway and research protocols in an effort to have higher success with a future formal application. Early involvement of a regulatory expert or consultant can lead to a reduction in time to market and important cost savings.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Book title
Series name and number
Publication date
2019-09-25
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Journal Issue
Comments
Recommended citation
Collection